AM2454
Development of a biodegradable implant for the delivery of GLP-1 agonists, indicated for the treatment of metabolic syndrome. The feasibility study is expected shortly.
read moreProducts
Development of a biodegradable implant for the delivery of GLP-1 agonists, indicated for the treatment of metabolic syndrome. The feasibility study is expected shortly.
read moreBiodegradable implant encapsulating dexamethasone for intravitreal use for 6 months. Glucocorticoid for the treatment of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.
read moreready-to-use applicator with 3 month implant
read moreready-to-use applicator for 1 month or 3 month implant
read more